Anesthesia; Functional
Conditions
Brief summary
Two approved treatments for spinal anesthesia will be compared in women undergoing cesarean section. It is usual to perform cesarean sections using spinal anesthesia with a local anesthetic (bupivacaine) plus some opioid, such as sufentanil or morphine. Both have been shown to decrease postoperative pain, but we try to check if one brings more benefit than the other.
Interventions
DRUGHyperbaric bupivacaine+Sufentanil
To evaluate in spinal anesthesia for elective cesarean section what association of hyperbaric bupivacaine 0.5% (0.06 mg Cm-1 in height) plus opioid: sufentanil (5 mcg)
DRUGHyperbaric bupivacaine+Morphine
To evaluate in spinal anesthesia for elective cesarean section what association of hyperbaric bupivacaine 0.5% (0.06 mg Cm-1 in height) plus opioid: morphine (0,01 mg)
Sponsors
Fundación Pública Andaluza Progreso y Salud
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
A randomized clinical trial, without masking techniques, is proposed in pregnant women who are to undergo elective caesarean section by subarachnoid anesthesia with hyperbaric bupivacaine associated with sufentanil or morphine
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
* Patients of at least 18 years. * Patients at least 36 weeks gestation. * Patients scheduled for non-urgent cesarean section. * Patients classified in the physical state of the American Society of Anesthesiologists (ASA) as grade I-II, and without important fetal pathological conditions. * Signature of informed consent that allows them to be part of the study.
Exclusion criteria
* Pregnant women who reject the spinal technique. * Patients with contraindication to spinal anesthesia. * Patients with ASA\> II classification. * Patients with multiple pregnancy. * Patients with three or more previous cesareans, * Patients with BMI greater than or equal to 40 kg / m2. * Language barrier. * Patients with pre-eclampsia. * Patients with a history of chronic pain. * Patients with a history of psychiatric or drug abuse. * Patients with allergy to any of the drugs used in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To evaluate the time it takes the patients administer a first analgesic bolus of morphine intravenous personally after subarachnoid anesthesia in elective cesarean section. | 3 days | To evaluate in spinal anesthesia for elective cesarean section what association of hyperbaric bupivacaine plus opioid: sufentanil or morphine, produces a longer time for the patient to administer a first analgesic bolus of intravenous morphine. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Levels of minor pain verbal scales | At 3, 6, 12 and 24 hours after surgery | The measure is based in EVA (Escala visual analógica del dolor) scale. EVA scale allows to measure the pain intensity that the patient describes with the maximum reproducibility among the observers. 1. Mild pain if the patient scores the pain as less than 3. 2. Moderate pain if the assessment is between 4 and 7. 3. Severe pain if the assessment is equal to or greater than 8. |
| Beginning of sitting and standing | At 48 hours after surgery | — |
| Mother´s side effects with respect to hemodynamic alteration, nausea, vomits, pruritus, tremor, urinary retention, sedation, respiratory depression, headaches, motor deficits, permanent sensory or autonomic deficits. | At intraoperative | — |
| Lower intravenous morphine consumption | 24 hours after surgery | — |
Other
| Measure | Time frame |
|---|---|
| Values in the Apgar test | At 1 and 5 minutes after birth |
Countries
Spain
Outcome results
None listed